Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies
European Journal of Cancer · 2024-02 · 198 · 113503
DOI: 10.1016/j.ejca.2023.113503 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Cancer, 2024-02. Verfasst von Adel Shahnam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: adel.shahnam@petermac.org. Hauptthemen laut MEDLINE: Melanoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Cancer Council South Australia, National Health and Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: adel.shahnam@petermac.org.
- Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia.
- Department of Medical Oncology, Liverpool Hospital, Sydney, New South Wales, Australia.
- Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
- The Centre of Cancer Medicine, University Hong Kong, Hong Kong.
- College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Förderung
- Cancer Council South Australia
- National Health and Medical Research Council
Zitieren
APA
Shahnam, A., Hitchen, N., Nindra, U., Manoharan, S., Desai, J., Tran, B., Solomon, B., Luen, S. J., Hui, R., Hopkins, A. M., & Sorich, M. J. (2024). Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies. European Journal of Cancer, 198, 113503. https://doi.org/10.1016/j.ejca.2023.113503
Vancouver
Shahnam A, Hitchen N, Nindra U, Manoharan S, Desai J, Tran B, et al. Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies. European Journal of Cancer. 2024;198:113503. doi:10.1016/j.ejca.2023.113503
BibTeX
@article{Shahnam2024,
author = {Shahnam, Adel and Hitchen, Nadia and Nindra, Udit and Manoharan, Sathya and Desai, Jayesh and Tran, Ben and Solomon, Benjamin and Luen, Stephen J and Hui, Rina and Hopkins, Ashley M and Sorich, Michael J},
title = {Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies},
journal = {European Journal of Cancer},
year = {2024},
volume = {198},
pages = {113503},
doi = {10.1016/j.ejca.2023.113503}
}
EUVIMED